Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Liquid vs Tablet Buprenorphine
NCT00000302Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in heroin dependence (2 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Drug use, Retention and 1 more. Status: completed.
02
Drugs
buprenorphine
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT00000302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000302.